/
Login
Analysis Scores
Damodaran ?
73/100
Dalio Risk ?
89/100
Piotroski ?
8/9
Strong
Graham ?
$94.6
Pahalı
Active Metric?
4/4
Confidence?
75%
Valuation
Potential?
+84.3%
ROIC ?
29.9%
DCF Value ?
243.86
Debt Cycle?
Early Expansion
Data
Data ?
5299
2005-08-11 → 2026-09-03
Risk Analysis (VaR)
Yüksek
252 days
Annual Volatility ?
%43.6
VaR 95% ?
%4.29
daily max loss
VaR 99% ?
%6.16
daily max loss
CVaR 95% ?
%5.50
expected loss (tail)
Max Drawdown ?
%26.1
30.03.2026 → 18.06.2026
Skewness ?
0.38
Parametrik%4.29
Historik%4.16
Cornish-Fisher%3.84
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Strong Uptrend
Price (139.27), TRAMA-99 line's %20.3 above. Strong uptrend continues. Technical momentum positive.
Price:: 139.27
TRAMA: 115.797
Difference: %+20.3
Profitability
Net Profit Margin
%31.0
Net profit margin %31.0 — very strong. Compared to previous quarter +9.4 point increase.
ROE – Özkaynak Getirisi (TTM)
%27.0
ROE %27.0 — high return on equity.
EBITDA Margin
%55.8
EBITDA margin %55.8 — operationally very efficient.
Gross Profit Margin
%37.6
Gross profit per revenue %37.6. Evaluate relative to sector.
Free Cash Flow Margin (TTM)
%21.8
TTM Free Cash Flow is %21.8'i. Strong FCF generation — profit quality is high.
Valuation
P/E Ratio
11.9x
Sector: 28.9x
F/K 11.9x — sector median's (28.9x) %59 below. Attractive for value investing.
P/B Ratio
3.92x
Sector: 3.89x
PD/DD 3.92x — sector median's (3.89x) %1 above.
EV/EBITDA
6.1x
Sector: 16.4x
EV/EBITDA 6.1x — sector median's (16.4x) %63 below. EBITDA’ya göre undervalued.
Indebtedness
Current Ratio
3.54x
Current ratio 3.54x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA
1.0x
Net Borç/EBITDA 1.0x — very low debt burden. Company can repay debt quickly.
Debt / Equity
0.68x
Borç/Özkaynak 0.68x — moderate financial leverage.
Interest Coverage
25.2x
Interest coverage 25.2x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY)
%+19.4
Revenue YoY %19.4 grew — healthy growth rate.
Net Profit Growth (YoY)
%+97.1
Net profit YoY %97.1 increased (2026/3) — extraordinary profit growth.
Score Explanations
Lothien Robustness
84/100
Very strong robustness score (84/100). Damodaran valuation, Dalio risk analysis and balance sheet quality criteria are largely met.
Very Strong
Potential
+84.3%
Plus %84.3 expected value (254.74) vs current price comparison. 4/4 valuation models give 'BUY' signal. Model confidence %75.
Components: PE target: 377.34 | P/B target: 152.70 | EV/EBITDA target: 373.76 | DCF target: 243.86
Damodaran Valuation
73/100
Strong Damodaran valuation (73/100). ROIC (%29.9) exceeds cost of capital, company creates value.
Strong
Dalio Risk Analysis
89/100
Low debt risk (89/100). Interest coverage ratio 25.2x — strong. Borç/EBITDA 1.0x — in healthy range.
Leverage: 85/100 | Debt Service: 100/100 | Quality: 100/100
ROIC – Sermaye Getirisi
%29.9
ROIC (%29.9) cost of capital 20.6 puan aşıyor → company creates value.
WACC: %9.3
DCF Discounted Cash Flow
243.86
DCF modeli 243.86 target value produced — compared to current price %76.5 undervalued.
Current price: 138.20
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
8/9
Strong Piotroski F-Score (8/9). Profitability, leverage and operational efficiency criteria are largely met.
Strong
Graham Intrinsic Value
$94.6
Güncel fiyat Graham valuenin %31.5 üzerinde ($94.6) — Expensive by Graham.
Expensive
⚖️ Sector Comparison
P/E Ratio
11.9x
vs 28.9x
Sector mediannın %59 below — cheap
P/B Ratio
3.92x
vs 3.89x
Compared to sector %1 more expensive (by book value)
EV/EBITDA
6.1x
vs 16.4x
Compared to sector %63 lower EV/EBITDA
ROIC vs WACC
%29.9
vs %9.3 WACC
ROIC 20.6 baz puan exceeds cost of capital
Net Profit Margin (TTM)
%23.7
vs %49.9 EBITDA margin
TTM net profit margin %23.7
Charts
Indicators
BB deviation
?
RSI thresholds
?
▲ içeriden alım ·
▼ içeriden satım ·
★ katalizör (haber-sezgisel) ·
■ 13D aktivist ·
■ 13G pasif
— SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
İçeriden Alım-Satım Akışı
Kim aldı, kim sattı, ne kadar
CF — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.